Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
---|
10/21/2008 | US7438203 Dermal penetration enhancers and drug delivery systems involving same |
10/21/2008 | CA2412708C Sulfur containing dermatological compositions and methods for reducing malodors in dermatological compositions |
10/21/2008 | CA2368823C Use of dopamine d3 receptor ligands for producing medicaments for treating kidney disorders |
10/21/2008 | CA2293346C Device and method for treatment of dysmenorrhea |
10/21/2008 | CA2232294C Bioactive factors of aloe vera plants |
10/21/2008 | CA2230452C Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
10/21/2008 | CA2220226C Improved methods for transfecting t cells |
10/21/2008 | CA2169071C Methods for modulating the human sexual response |
10/21/2008 | CA2042064C C-erbb-2 external domain:gp75 |
10/20/2008 | CA2629419A1 Dietary supplement for the compensation of nutritional deficiency |
10/16/2008 | WO2008124699A1 A method of using proteasome inhibitors in combination with histone deacetylase inhibitors to treat cancer |
10/16/2008 | WO2008124522A2 Amylin formulations |
10/16/2008 | WO2008124483A1 Protein cage immunotherapeutics |
10/16/2008 | WO2008124161A1 Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha |
10/16/2008 | WO2008124088A2 Compositions and methods for the treatment of heart failure |
10/16/2008 | WO2008124085A2 Methods of using combinations of mek and jak-2 inhibitors |
10/16/2008 | WO2008124081A2 Rapid dissolution of combination products |
10/16/2008 | WO2008124009A2 Treating glaucoma |
10/16/2008 | WO2008123395A1 Ocular hypotensive agent comprising compound capable of inhibiting histone deacetylase as active ingredient |
10/16/2008 | WO2008122798A2 Pharmaceutical composition of an eg5 inhibitor and a microtubule interfering agent for the treatment of cancer |
10/16/2008 | WO2008122779A1 Combination of a purine-based cdk inhibitor with a tyrosine kinase inhibitor and use thereof in the treatment of proliferative disorders |
10/16/2008 | WO2008057337A3 Use of dipeptidyl peptidase iv inhibitors for preventing, delaying or reducing the occurance of edema |
10/16/2008 | WO2008026156A3 Therapeutic compositions comprising a specific endothelin receptor antagonist and a pde5 inhibitor |
10/16/2008 | WO2007115289A8 Combinations comprising bcr-abl/c-kit/pdgf-r tk inhibitors for treating cancer |
10/16/2008 | WO2007094924A3 Human telomerase reverse transcriptase peptides |
10/16/2008 | US20080255557 High strength suture with absorbable core and suture anchor combination |
10/16/2008 | US20080255252 Infectious Aetiology of Prostatic Disease and Methods to Identify Causative Agents |
10/16/2008 | US20080255250 Compounds and Compositions for Delivering Active Agents |
10/16/2008 | US20080255221 Novel hydroxamates as therapeutic agents |
10/16/2008 | US20080255214 Novel hydroxamates as therapeutic agents |
10/16/2008 | US20080255209 Combination of a NSAID and a PDE-4 inhibitor |
10/16/2008 | US20080255132 Combination Therapy Comprising the Use of Et-743 and Paclitaxel for Treating Cancer |
10/16/2008 | US20080254527 VON WILLEBRAND FACTOR (vWF) - CLEAVING PROTEASE |
10/16/2008 | US20080254506 Claudin polypeptides |
10/16/2008 | US20080254447 Using CpG site methylation of breast cancer tumor antigens as evaluative tools in prognosing/diagnosing cell proliferative disorders |
10/16/2008 | US20080254142 Compositions and methods for nutrition supplementation |
10/16/2008 | US20080254127 Inhalation particles incorporating a combination of two or more active ingredients |
10/16/2008 | US20080254105 Pharmaceutical carrier device suitable for delivery of pharmaceutical compounds to mucosal surfaces |
10/16/2008 | US20080254064 Compositions and methods for priming monocytic dendritic cells and t cells for th-1 response |
10/16/2008 | US20080254040 Antagonists of receptors of enothelial growth factor, platelet-derived growth factor, fibroblast growth factor, epidermal growth factors, HER2, IGF1R, HGFR or c-Kit, which is further an antagonist of a src tyrosine kinase family member, and chemotherapeutic agent; co-treatment with radiation therapy |
10/16/2008 | US20080254028 Caspase-8 interacting polypeptide (Cari) for use in identifying modulators for prevention and treatment of autoimmune, inflammatory, connective tissue and liver disorders |
10/16/2008 | US20080254019 Therapeutic Agents and Therapeutic Methods For Treating Injured Tissue |
10/16/2008 | US20080253999 Methods For Differentiating Stem Cells and Uses Thereof in the Treatment of Dental Conditions |
10/16/2008 | US20080253993 Immunogenic Egfr Peptides Comprising Foreign T Cell Stimulating Epitope |
10/16/2008 | US20080253991 Using glutamic acid decarboxylase (GAD) autoantigen, cd3 specific antibodies and lymphocyte specific antibodies to treat and prevent new onset type I diabetes in mammals |
10/16/2008 | CA2683641A1 Methods of treating cancer using pyridopyrimidinone inhibitors of pi3k alpha |
10/16/2008 | CA2682872A1 Rapid dissolution of combination products |
10/16/2008 | CA2682234A1 Compositions and methods for the treatment of heart failure |
10/16/2008 | CA2680838A1 Intraocular pressure-lowering agent comprising compound having histone deacetylase inhibitory effect as active ingredient |
10/15/2008 | EP1980271A1 Medicine for transnasal administration |
10/15/2008 | EP1980263A1 Combinations of immunosuppressive agents for the treatment or prevention of graft rejections |
10/15/2008 | EP1980257A1 Compositions and uses of galectin antagonists |
10/15/2008 | EP1980252A2 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
10/15/2008 | EP1980249A2 Combination comprising an at1-receptor antagonist and an insulin secretion enhancer or an insulin sensitiser |
10/15/2008 | EP1980243A1 Liposome preparation |
10/15/2008 | EP1979002A2 Combination of igfr inhibitor and anti-cancer agent |
10/15/2008 | EP1978993A2 Compositions and methods for diagnosing and treating cancer |
10/15/2008 | EP1978984A2 Nutritional system and methods for increasing longevity |
10/15/2008 | EP1978968A2 Cationic steroid antimicrobial compositions for treating or preventing hiv infections |
10/15/2008 | EP1978962A2 Compositions and methods of treatment using modulators of motonueron diseases |
10/15/2008 | EP1978955A1 New pharmaceutical compositions based on anticholinergics and andolast |
10/15/2008 | EP1978949A2 Combination preparation for improving sperm quality |
10/15/2008 | EP1694338B1 Use of mimetics of superoxide dismutase and of reductase glutathione in the form of anticancer drugs |
10/15/2008 | EP1660085B1 Pyridylpyrrole derivatives active as kinase inhibitors |
10/15/2008 | EP1476423B1 Arylsulfonamidobenzylic compounds |
10/15/2008 | EP1458722B1 Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
10/15/2008 | EP1432379B1 Methods for inhibiting cognitive deterioration in adults with down's syndrome |
10/15/2008 | EP1427409B1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s) |
10/15/2008 | EP1414421B1 The treatment of lipodystrophy with inhibitors of the renin angiotensin system |
10/15/2008 | EP1411982B1 Modulators of p-selectin glycoprotein ligand 1 |
10/15/2008 | EP1411940B1 Bridged piperidine derivatives as melanocortin receptor agonists |
10/15/2008 | EP1383786B1 Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
10/15/2008 | EP1379207A4 Composition for freshening nostrils and sinus cavities |
10/15/2008 | EP1375486B1 Nitrogen-containing heteroaryl compounds having hiv integrase inhibitory activity |
10/15/2008 | EP1373257B9 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
10/15/2008 | EP1351742B1 Compositions for inducing islet neogenesis, containing gastrin/cck receptor ligands and egf receptor ligands |
10/15/2008 | EP1296995B1 3'-prodrugs of 2'-deoxy-beta-l-nucleosides |
10/15/2008 | EP1272517B1 Multiprotein-complexes comprising a nmda receptor and uses thereof |
10/15/2008 | EP1242456B1 Scfv antibodies against disease associated molecules |
10/15/2008 | EP1019057B1 A method of preventing or treating estrogen-dependent diseases and disorders |
10/15/2008 | EP0841946B2 Methods for treatment of allergic asthma |
10/15/2008 | CN101287496A Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration |
10/15/2008 | CN101287495A Direct compression formulation of DPP-IV inhibitors and glitazones, and process |
10/15/2008 | CN101287494A Methods for treating dermatitis using mutant human IL-4 compositions |
10/15/2008 | CN101287461A Use of 5-amido-1h-pyrrole-2-nitrile derivative as progesterone receptor modulators |
10/15/2008 | CN101285061A Fungal cell wall synthesis gene |
10/15/2008 | CN101284865A New compound and its medicine use |
10/15/2008 | CN101283995A Different pharmaceutical uses alpha2delta ligands |
10/15/2008 | CN101283978A Anticancer sustained-release gel injection containing platinum compound |
10/15/2008 | CN101283977A Sustained-release gel injection loaded with platinum compound and alkyl agent |
10/15/2008 | CN101283976A Anticancer sustained-release gel injection containing taxone medicine |
10/15/2008 | CN101283975A Anticancer sustained-release gel injection containing neonatal blood vessel inhibitor |
10/15/2008 | CN101283974A Anticancer sustained-release gel injection and preparation method thereof |
10/15/2008 | CN101283933A Artificial crystalline lens of blocking eaves type limitation after cataract |
10/15/2008 | CN100425284C Methods for glucagon suppression |
10/15/2008 | CN100425241C Glaucoma-treating agent consisting of RHo kinase inhibitor and prostaglandin |
10/14/2008 | US7435870 administering nucleic acids to fish and detecting changes in messenger RNA in the cells, tissues or organs using a cDNA microarray, in response to the nucleic acids; screening drugs for neovscularization, apoptosis or toxic activity |
10/14/2008 | US7435806 Detection of preferential transcription factor; obtain library, screen with probe, detect hybridization, recover clone, monitor transcriptional activity of protein codes in cloned nucleotide sequences |
10/14/2008 | US7435756 Preparation and diabetic use of gibberellins |
10/14/2008 | US7435745 Methods and compositions for inhibition of angiogenesis |